Literature DB >> 11113103

Pentoxifylline and alcoholic hepatitis.

T R Morgan, C J McClain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11113103     DOI： 10.1053/gast.2000.20826

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  6 in total

1.  Management of alcoholic hepatitis.

Authors:  Timothy R Morgan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-02

2.  Prevalence of septic events, type 1 hepatorenal syndrome, and mortality in severe alcoholic hepatitis and utility of discriminant function and MELD score in predicting these adverse events.

Authors:  Sumita Verma; Ketan Ajudia; Michel Mendler; Allan Redeker
Journal:  Dig Dis Sci       Date:  2006-08-22       Impact factor: 3.199

3.  A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH).

Authors:  Yin-Mei Lee; Dede S Sutedja; Chun-Tao Wai; Yock-Young Dan; Myat-Oo Aung; Lei Zhou; Chee-Leong Cheng; Aileen Wee; Seng-Gee Lim
Journal:  Hepatol Int       Date:  2008-02-28       Impact factor: 6.047

4.  A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis.

Authors:  Nicholas C Boetticher; Craig J Peine; Paul Kwo; Gary A Abrams; Tushar Patel; Bashar Aqel; Lisa Boardman; Gregory J Gores; William S Harmsen; Craig J McClain; Patrick S Kamath; Vijay H Shah
Journal:  Gastroenterology       Date:  2008-09-13       Impact factor: 22.682

Review 5.  Alcoholic hepatitis: a comprehensive review of pathogenesis and treatment.

Authors:  Maneerat Chayanupatkul; Suthat Liangpunsakul
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

Review 6.  Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease.

Authors:  Ji Ye Hyun; Seul Ki Kim; Sang Jun Yoon; Su Been Lee; Jin-Ju Jeong; Haripriya Gupta; Satya Priya Sharma; Ki Kwong Oh; Sung-Min Won; Goo Hyun Kwon; Min Gi Cha; Dong Joon Kim; Raja Ganesan; Ki Tae Suk
Journal:  Int J Mol Sci       Date:  2022-08-06       Impact factor: 6.208
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.